News

Filter

Inspire/InSite's AzaSite debuts in the USA

20-08-2007

InSite Vision, a US ophthalmic therapeutics, diagnostics and drug delivery company, has announced the…

AzaSiteAzithromycinAzithromycin Ophthalmic SolutionZithromaxZithromax InjectionZmax

Inspire to sell $75M of stock

30-07-2007

Inspire Pharmaceuticals says that it has entered into a securities purchase agreement for the sale of…

AzaSiteAzithromycinAzithromycin Ophthalmic SolutionZithromaxZithromax InjectionZmax

InSite and Inspire in ocular antibiotic deal

26-02-2007

InSite Vision, a specialist developer of drugs for ophthalmic indications, has signed a licensing agreement…

AzaSiteAzithromycinAzithromycin Ophthalmic SolutionZithromaxZithromax InjectionZmax

InSite prepares NDA on AzaSite

04-07-2005

The USA's InSite Vision, an ophthalmic therapeutics, diagnostics and drug-delivery specialist, has had…

AzaSiteAzithromycin Ophthalmic Solution

InSite wins Azalide eye care EPO patent

20-06-2005

InSite Vision, a US ophthalmic therapeutics specialist says that the European Patent Office has issued…

AzaSiteAzithromycin Ophthalmic Solution

InSite enters AzaSite supply deal

23-05-2005

InSite Vision, a US ophthalmic therapeutics, diagnostics and drug-delivery company, says that it has…

AzaSiteAzithromycinAzithromycin Ophthalmic SolutionZithromaxZithromax InjectionZmax

InSite Vision completes $16.5M placing

21-06-2004

InSite Vision, a USA-based ophthalmic products company focused on ocular infections, has completed a…

AzaSiteAzithromycin Ophthalmic Solution

COMPANY SPOTLIGHT

Menarini

Back to top